Adaptive Biotechnologies Corporation (FRA:1HM)
Germany · Delayed Price · Currency is EUR 13.84
+0.31 (2.29%)
At close: Dec 19, 2025
Adaptive Biotechnologies Market Cap
Adaptive Biotechnologies has a market cap or net worth of €2.21 billion as of December 22, 2025. Its market cap has increased by 157.40% in one year.
Market Cap
2.21B
Enterprise Value
2.21B
Revenue
215.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
€13.84
Market Cap Chart
Since June 27, 2019, Adaptive Biotechnologies's market cap has decreased from 4.20B to 2.21B, a decrease of -47.27%. That is a compound annual growth rate of -9.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 2.21B | 159.18% |
| Dec 31, 2024 | 854.57M | 33.16% |
| Dec 29, 2023 | 641.78M | -37.23% |
| Dec 30, 2022 | 1.02B | -70.64% |
| Dec 31, 2021 | 3.48B | -47.33% |
| Dec 31, 2020 | 6.61B | 99.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 243.93B |
| Siemens Aktiengesellschaft | 183.57B |
| Allianz SE | 146.73B |
| Deutsche Telekom AG | 130.04B |
| Siemens Energy AG | 102.30B |
| Rheinmetall AG | 71.12B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 70.51B |
| Deutsche Bank Aktiengesellschaft | 62.30B |